REMIBRUTINIB TREATMENT HAS NO CLINICAL IMPACT ON MEAN BLOOD CELL COUNTS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: POOLED SAFETY ANALYSIS FROM REMIX-1 AND REMIX-2 STUDIES